Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
CC transcript
Inv. presentation
Jazz Pharmaceuticals plc (JAZZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance – Strong execution delivered second quarter 2023 total revenues of $957 million –"
05/10/2023 8-K Quarterly results
Docs: "Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance Focus on commercial execution drove 1Q23 total revenues of $892.8 million"
11/09/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
Docs: "Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance"
05/04/2022 8-K Quarterly results
11/09/2021 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS AND RAISES FULL YEAR EARNINGS GUIDANCE"
08/03/2021 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS"
05/04/2021 8-K Quarterly results
11/02/2020 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS"
08/04/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS"
08/06/2019 8-K Quarterly results
05/07/2019 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS"
11/06/2018 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS"
05/08/2018 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS"
11/07/2017 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS"
08/08/2017 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2017 FINANCIAL RESULTS"
05/09/2017 8-K Form 8-K - Current report
11/08/2016 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2016 FINANCIAL RESULTS Total Revenues Increased 10% to $374 Million Initiated Rolling NDA Submission for Vyxeos"
08/09/2016 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2016 FINANCIAL RESULTS Strong Top- and Bottom-line Growth Total Revenues of $381 Million Driven by Strong Sales of Xyrem, Erwinaze and Defitelio"
05/10/2016 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2016 FINANCIAL RESULTS Strong Top- and Bottom-line Growth Total Revenues of $336 Million Driven by Strong Sales of Xyrem"
11/09/2015 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS"
08/05/2015 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS"
05/07/2015 8-K Quarterly results
Docs: "Exhibit 99.1 JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2015 FINANCIAL RESULTS First Quarter 2015 Total Revenues of $309 Million, Driven by Strong Sales of Xyrem, Erwinaze and Defitelio"
11/04/2014 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2014 FINANCIAL RESULTS AND UPDATED GUIDANCE"
08/05/2014 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2014 FINANCIAL RESULTS AND UPDATED GUIDANCE"
05/08/2014 8-K Quarterly results
Docs: "JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2014 FINANCIAL RESULTS"
11/05/2013 8-K Form 8-K - Current report
08/06/2013 8-K Form 8-K - Current report
05/07/2013 8-K Form 8-K - Current report
11/08/2012 8-K Form 8-K - Current report
08/07/2012 8-K Form 8-K - Current report
05/08/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy